Skip to main content

U.S. will still pay at least twice as much after negotiating drug prices

By Reuters  
   September 03, 2024

The U.S. government's first-ever negotiated prices for prescription drugs are still on average more than double, and in some cases five times, what drugmakers have agreed to in four other high-income countries.

Full story


Get the latest on healthcare leadership in your inbox.